Improving treatment outcome for cervical cancer using 2-point assessment of quality of life among Nigerian women: a protocol for a multi-centre study.

dc.contributor.authorUmemmuo, M. U.
dc.contributor.authorEleje, G. U.
dc.contributor.authorOluwasola, T. A.
dc.contributor.authorEzeanochie, M.
dc.contributor.authorUsman, H. A.
dc.contributor.authorGaladanchi, J. S.
dc.contributor.authorAgbanu, C. M.
dc.contributor.authorRabiu, A.
dc.date.accessioned2026-02-04T09:33:59Z
dc.date.issued2023
dc.description.abstractBackground: Cervical cancer is the fourth most common cancer among women globally, with quality of life (QOL) being a major concern for patients with cervical cancer, especially in low- and middle-income countries (LMICs). This is largely due to the advanced nature of the disease at presentation. Although there are a higher number of studies focusing on the QOL of high-income countries, the QOL of cervical cancer patients in LMICs is not available. The aim of this study is to evaluate QOL among women with cervical cancer in Nigeria using a 2-point assessment. Methods: A multi-center prospective cohort study will be conducted in 6 tertiary health facilities randomly selected from the 6 geopolitical zones of Nigeria and consisting of a 2-point assessment of the QOL of participants at the time of diagnosis of cervical cancer and after treatment. Women who were recently diagnosed with histologically confirmed cervical cancer (treatment naïve) will be included. QOL will be assessed using Quality of Life Questionnaire domains (EORTC QLQ30) as developed by the European Organization for Research and Treatment of Cancer (EORTC). In addition to the QOL assessment, relevant and clinicopathological variables will be obtained using a self-structured data extraction sheet designed for this study. All data will be anonymized and will be analyzed using SPSS version 25. Levels of QOL will be calculated using EORTC QLQ30. Ethical approval was obtained from National Health Research Ethics Committee (NHREC/01/01/2007-08/11/2021). Discussion : In view of the paucity of data on QOL in LMICs like Nigeria, where most women with cervical cancer present with advanced disease, this research was designed to help in formulating evidence-based interventions to improve the QOL and treatment outcomes provided to women with cervical cancer in Nigeria and other LMICs. The study is expected to fill these knowledge gaps.
dc.identifier.issn1179-5549
dc.identifier.otherui_art_umemmuo_improving_2023
dc.identifier.otherClinical Insights: Oncology 17, pp. 1 – 4
dc.identifier.urihttps://repository.ui.edu.ng/handle/123456789/11827
dc.language.isoen
dc.subjectCervical cancer
dc.subjectwomen
dc.subjectNigeria
dc.subjectquality of life
dc.subjecttreatment
dc.titleImproving treatment outcome for cervical cancer using 2-point assessment of quality of life among Nigerian women: a protocol for a multi-centre study.
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
(66) ui_art_umemmuo_improving_2023.pdf
Size:
464.07 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.61 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections